Cardio Diagnostics Holdings, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $5.8M
- Price
- $1.91
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.02%
- Volume
- 48.9K
About
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Quick stats
Shares outstanding3.0M
Computed float2.7M
Float / shares91.0%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001870144
AI Summary
AI-generated1/15
standardbullishoperations update
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
Cardio Diagnostics launched its in-house, high complexity CLIA-certified laboratory in Iowa City, assuming end-to-end control of its multi-omics clinical tests.
This vertical integration replaces previous third-party arrangements and is expected to improve unit economics, supporting gross margins of approximately 40% at scale.
The new facility reduces turnaround times to 7-10 business days and secures key state licenses including California, Maryland, Rhode Island, and Pennsylvania.